1. Division of Cardiology, McGill University Health Centre, Montreal, QC, Canada (A.S.).
2. Division of Cardiovascular Medicine, Stanford University School of Medicine, CA (A.S.).
3. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (N.J.P., J.B.G., M.T.R., C.G.).
4. Verily Life Sciences and Duke University School of Medicine, Durham, NC (R.M.C.).
5. UT Southwestern, Dallas (D.K.M.).
6. University of Wisconsin, Madison (D.D.).
7. Boehringer-Ingelheim International, Ingelheim am Rhein, Germany (J.T.G.).
8. McMaster University, Hamilton, ON, Canada (H.C.G.).
9. Novo Nordisk, Plainsboro, NJ (T.H.).
10. Diabetes Trials Unit, University of Oxford, UK (R.R.H.).
11. Sanofi US, Bridgewater, NJ (F.C.L.).
12. University of Toronto, ON, Canada (L.A.L.).
13. Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA (M.A.P.).
14. University of Colorado School of Medicine, Denver (J.R.).
15. Eli Lilly & Co, Indianapolis, IN (J.S.R.).
16. National Heart, Lung, and Blood Institute, Bethesda, MD (Y.R.).
17. Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD (R.T.).
18. TIMI Study Group, Harvard Medical School, Boston, MA (S.W.).
19. University of Glasgow, Scotland, UK (J.M.).